… agents, and thus to a relevant progress in the treatment of … treatment options such as
effective targeted therapy [9,10]. … an overview on targeted therapy options in advanced and …

… study is to investigate categorized targeted therapy strategies in treating NSCLC. In the …
NSCLC common treatments and then continue our study by focusing on the targeted therapy of …

… to target key molecules and pathways in a selective fashion, leading to the development of
multiple targeted therapies for the treatment of … on novel therapies/treatment combinations …

… There has been a considerable amount of effort in understanding the depth of molecular
biology of SCLC and utilizing this knowledge to develop targeted therapies for this disease. …

… ), MET, or the mechanistic target of rapamycin (mTOR) have been examined with new findings
[Figure 1 and Table 1]. We introduce the current knowledge of targeting therapies for GC. …

… chemotherapy has a limited role in the treatment of advanced or metastatic disease. For
the purpose of this review, we will focus on targeted therapy. Pharmacologic Treatment …

… In this review, we provide background information on the molecular biology of cervical
cancer and summarize immunotherapy studies, targeted therapies, including those with …

… targeted therapy based on molecular subtyping. Since the early 2000s, multiple targeted
therapies have demonstrated efficacy in treating … updated literature regarding targeted therapies …

… therapeutic agents for the treatment of R/M HNSCC. As a result, cetuximab, a monoclonal
antibody targeting … and nivolumab, monoclonal antibodies targeting programmed cell death 1 (…

… approach and application of targeted therapies. With the previous … treatments of targeted
therapies in may provide the insight into the choice of ALK-TKIs in different lines of treatment …